epcs

EPCS requires both platforms and prescribers to meet DEA rules for identity proofing and two‑factor authentication. Digital certificates—such as IdenTrust’s FBCA‑cross‑certified option—cover identity verification, but platforms must pair them with their own two‑factor method. IdenTrust supports three approaches: platform‑managed authentication, hardware tokens, and mobile app authentication. Platforms should plan certificate strategy early, consider multiple authentication methods for diverse clinical settings, and help prescribers select the correct certificate type. These choices have long‑term impact on compliance, workflow, and audit readiness.

Digitally signed email relies on S/MIME certificates to authenticate the sender and protect message integrity, allowing inboxes to trust the signer’s identity and validate that the email hasn’t been altered. Healthcare organizations depend on this technology to safeguard PHI, using MDM tools to distribute certificates across managed devices so users can sign and encrypt messages consistently. Secure exchanges require both parties’ certificates: senders use a recipient’s public key to encrypt messages, and recipients decrypt them with their own private key. This model ensures non‑repudiation, controlled access to sensitive data, and HIPAA‑aligned protection for clinical communication. For regulated environments needing verifiable email identity and encrypted delivery, S/MIME certificates provide essential trust.